2013 Fiscal Year Final Research Report
Is phosphorylated caspase 9 a new marker of mitotic catastrophe?
| Project/Area Number |
23590396
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Human pathology
|
|---|
| Research Institution | Kobe University |
|---|
Principal Investigator |
SHINTANI Michiko (田中 路子) 神戸大学, 保健学研究科, 助教 (40207147)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
KAMOSHIDA Shingo 神戸大学, 大学院保健学研究科, 教授 (70351020)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
MATSUOKA Hiroshi 藤田保健衛生大学, 医学部, 講師 (40367719)
SANGAWA Akiko 大阪赤十字病院, 病理部, 臨床検査技師
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Keywords | 胃癌 / 大腸癌 / リン酸化カスパーゼ9 / サバイビン / Smac/DIABLO / 細胞死 / 免疫組織化学 |
|---|
| Research Abstract |
Initially, we examined whether phosphorylated caspase 9 is a new marker of mitotic catastrophe. However, this was difficult to prove. Next, we investigated the expression rates of survivin and Smac/DIABLO in gastric and colorectal carcinomas by immunohistochemistry. We observed that gastric and colorectal carcinomas differ in their levels of survivin and Smac/DIABLO expression; both expressions were significantly higher in colorectal carcinoma than in gastric carcinoma. Additionally, we showed that there is a correlation between the expression of Smac/DIABLO and survivin in well-to-moderately differentiated colorectal adenocarcinomas. On the basis of these results, we consider that the expression of Smac/DIABLO in colorectal carcinoma may be upregulated to suppress the anti-apoptotic effect of survivin.
|
Research Products
(6 results)
